TrialThe Lancet. Neurology2019

Safety and efficacy of co-careldopa as an add-on therapy to occupational and physical therapy in patients after stroke (DARS): a randomised, double-blind, placebo-controlled trial.

Gary A Ford et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.